StageZero Technologies

StageZero Technologies is a healthcare company that developed and commercialized a proprietary platform, Aristotle®, which can accurately detect the early stages of cancer and other diseases through a patient's blood sample. The platform utilizes machine learning and artificial intelligence technology, which can analyze the nuances of thousands of RNA biomarkers in the blood to give accurate diagnostic results. The company's mission is to help patients detect and treat cancer faster, leading to better health outcomes.